Use of immediate release melatonin in psychiatry: BMI impacts the daily-dose
- 24 December 2020
- journal article
- research article
- Published by Elsevier BV in L'Encéphale
- Vol. 47 (2), 96-101
- https://doi.org/10.1016/j.encep.2020.08.010
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Pediatric Prolonged-Release Melatonin for Sleep in Children with Autism Spectrum Disorder: Impact on Child Behavior and Caregiver’s Quality of LifeJournal of Autism and Developmental Disorders, 2019
- Clock Genes and Light Signaling Alterations in Bipolar Disorder: When the Biological Clock Is OffBiological Psychiatry, 2018
- Meta-Analysis: Melatonin for the Treatment of Primary Sleep DisordersPLOS ONE, 2013
- A double-blind, randomized, placebo-controlled trial of adjunctive ramelteon for the treatment of insomnia and mood stability in patients with euthymic bipolar disorderJournal of Affective Disorders, 2013
- Melatonin in autism spectrum disorders: a systematic review and meta‐analysisDevelopmental Medicine and Child Neurology, 2011
- Melatonin in children with autistic spectrum disorders: recent and practical dataEuropean Child & Adolescent Psychiatry, 2011
- A randomized, placebo-controlled study of adjunctive ramelteon in ambulatory bipolar I disorder with manic symptoms and sleep disturbanceInternational Clinical Psychopharmacology, 2011
- The Use of Exogenous Melatonin in Delayed Sleep Phase Disorder: A Meta-analysisSleep, 2010
- Sleep in children with autistic spectrum disorderSleep Medicine, 2010
- The basic physiology and pathophysiology of melatoninSleep Medicine Reviews, 2005